nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.296	0.335	CbGbCtD
Tolbutamide—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0951	0.108	CbGbCtD
Tolbutamide—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0898	0.102	CbGbCtD
Tolbutamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0716	0.0811	CbGbCtD
Tolbutamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0716	0.0811	CbGbCtD
Tolbutamide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0647	0.0733	CbGbCtD
Tolbutamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0595	0.0675	CbGbCtD
Tolbutamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0595	0.0675	CbGbCtD
Tolbutamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0451	0.0511	CbGbCtD
Tolbutamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0301	0.0341	CbGbCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Aminophylline—chronic obstructive pulmonary disease	0.00344	0.0896	CcSEcCtD
Tolbutamide—Gliclazide—VEGFA—chronic obstructive pulmonary disease	0.00325	0.694	CrCbGaD
Tolbutamide—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00291	0.0757	CcSEcCtD
Tolbutamide—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.0544	CcSEcCtD
Tolbutamide—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.0295	CcSEcCtD
Tolbutamide—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.0295	CcSEcCtD
Tolbutamide—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0278	CcSEcCtD
Tolbutamide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000942	0.0245	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000924	0.0241	CcSEcCtD
Tolbutamide—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.0236	CcSEcCtD
Tolbutamide—Gliclazide—ALB—chronic obstructive pulmonary disease	0.000874	0.186	CrCbGaD
Tolbutamide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00085	0.0221	CcSEcCtD
Tolbutamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000712	0.00957	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000693	0.00931	CbGpPWpGaD
Tolbutamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000675	0.0176	CcSEcCtD
Tolbutamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00067	0.0175	CcSEcCtD
Tolbutamide—CYP2C18—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000648	0.00871	CbGpPWpGaD
Tolbutamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000636	0.0165	CcSEcCtD
Tolbutamide—CYP2C8—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000635	0.00854	CbGpPWpGaD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000634	0.00852	CbGpPWpGaD
Tolbutamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.0164	CcSEcCtD
Tolbutamide—CYP2C18—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000626	0.00841	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000623	0.00837	CbGpPWpGaD
Tolbutamide—CYP2C8—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000611	0.00821	CbGpPWpGaD
Tolbutamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000592	0.0154	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000581	0.0151	CcSEcCtD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000577	0.00775	CbGpPWpGaD
Tolbutamide—CYP2C18—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00057	0.00766	CbGpPWpGaD
Tolbutamide—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000567	0.00762	CbGpPWpGaD
Tolbutamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000567	0.0148	CcSEcCtD
Tolbutamide—Probenecid—ALB—chronic obstructive pulmonary disease	0.000561	0.12	CrCbGaD
Tolbutamide—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000545	0.00733	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000536	0.00721	CbGpPWpGaD
Tolbutamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000535	0.0139	CcSEcCtD
Tolbutamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000521	0.0136	CcSEcCtD
Tolbutamide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.0136	CcSEcCtD
Tolbutamide—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000517	0.00695	CbGpPWpGaD
Tolbutamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000515	0.00692	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000514	0.00691	CbGpPWpGaD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000514	0.00691	CbGpPWpGaD
Tolbutamide—KCNJ11—Type II diabetes mellitus—TNF—chronic obstructive pulmonary disease	0.000514	0.0069	CbGpPWpGaD
Tolbutamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.0131	CcSEcCtD
Tolbutamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000499	0.00671	CbGpPWpGaD
Tolbutamide—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000497	0.00668	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000483	0.00649	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000478	0.00643	CbGpPWpGaD
Tolbutamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.0124	CcSEcCtD
Tolbutamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000478	0.0124	CcSEcCtD
Tolbutamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.0124	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.0122	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000469	0.0122	CcSEcCtD
Tolbutamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000468	0.0122	CcSEcCtD
Tolbutamide—CYP2C8—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000462	0.0062	CbGpPWpGaD
Tolbutamide—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000461	0.00619	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000459	0.012	CcSEcCtD
Tolbutamide—CYP2C18—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000455	0.00611	CbGpPWpGaD
Tolbutamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.0118	CcSEcCtD
Tolbutamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00045	0.0117	CcSEcCtD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000448	0.00602	CbGpPWpGaD
Tolbutamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000447	0.0116	CcSEcCtD
Tolbutamide—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000444	0.00597	CbGpPWpGaD
Tolbutamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.0115	CcSEcCtD
Tolbutamide—ABCC8—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000434	0.00584	CbGpPWpGaD
Tolbutamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000431	0.0112	CcSEcCtD
Tolbutamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.0112	CcSEcCtD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00043	0.00579	CbGpPWpGaD
Tolbutamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000424	0.011	CcSEcCtD
Tolbutamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.011	CcSEcCtD
Tolbutamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000423	0.011	CcSEcCtD
Tolbutamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000422	0.011	CcSEcCtD
Tolbutamide—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00566	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000421	0.00566	CbGpPWpGaD
Tolbutamide—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000412	0.00554	CbGpPWpGaD
Tolbutamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.0106	CcSEcCtD
Tolbutamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.0104	CcSEcCtD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0004	0.00537	CbGpPWpGaD
Tolbutamide—SLCO1A2—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000399	0.00536	CbGpPWpGaD
Tolbutamide—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000396	0.00533	CbGpPWpGaD
Tolbutamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.01	CcSEcCtD
Tolbutamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000384	0.01	CcSEcCtD
Tolbutamide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000382	0.00514	CbGpPWpGaD
Tolbutamide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00985	CcSEcCtD
Tolbutamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000376	0.0098	CcSEcCtD
Tolbutamide—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000376	0.00505	CbGpPWpGaD
Tolbutamide—CYP2C18—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000373	0.00502	CbGpPWpGaD
Tolbutamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00945	CcSEcCtD
Tolbutamide—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000361	0.00486	CbGpPWpGaD
Tolbutamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.00938	CcSEcCtD
Tolbutamide—ABCC8—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000354	0.00476	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000354	0.00476	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000343	0.00461	CbGpPWpGaD
Tolbutamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00891	CcSEcCtD
Tolbutamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00891	CcSEcCtD
Tolbutamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00034	0.00886	CcSEcCtD
Tolbutamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00034	0.00886	CcSEcCtD
Tolbutamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000338	0.00455	CbGpPWpGaD
Tolbutamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00873	CcSEcCtD
Tolbutamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00868	CcSEcCtD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000333	0.00447	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000328	0.00441	CbGpPWpGaD
Tolbutamide—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000327	0.00439	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000325	0.00436	CbGpPWpGaD
Tolbutamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00842	CcSEcCtD
Tolbutamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.0084	CcSEcCtD
Tolbutamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000323	0.0084	CcSEcCtD
Tolbutamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000321	0.00836	CcSEcCtD
Tolbutamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00823	CcSEcCtD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000316	0.00424	CbGpPWpGaD
Tolbutamide—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00411	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.0041	CbGpPWpGaD
Tolbutamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00793	CcSEcCtD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000297	0.00399	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000273	0.00367	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000272	0.00366	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00027	0.00363	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000269	0.00362	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00355	CbGpPWpGaD
Tolbutamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00682	CcSEcCtD
Tolbutamide—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00026	0.0035	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.00334	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000241	0.00324	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000236	0.00317	CbGpPWpGaD
Tolbutamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00608	CcSEcCtD
Tolbutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.00312	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000228	0.00306	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000225	0.00302	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000222	0.00298	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00022	0.00295	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.00289	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.00287	CbGpPWpGaD
Tolbutamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000212	0.00285	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000209	0.00281	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000206	0.00277	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000205	0.00275	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—APIP—chronic obstructive pulmonary disease	0.000199	0.00267	CbGpPWpGaD
Tolbutamide—CYP2C18—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00267	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000198	0.00266	CbGpPWpGaD
Tolbutamide—CYP2C18—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00263	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000196	0.00263	CbGpPWpGaD
Tolbutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00258	CbGpPWpGaD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.00257	CbGpPWpGaD
Tolbutamide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00254	CbGpPWpGaD
Tolbutamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000188	0.0049	CcSEcCtD
Tolbutamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.00483	CcSEcCtD
Tolbutamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.0048	CcSEcCtD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00243	CbGpPWpGaD
Tolbutamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00455	CcSEcCtD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.00234	CbGpPWpGaD
Tolbutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.0023	CbGpPWpGaD
Tolbutamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00442	CcSEcCtD
Tolbutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00227	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—APIP—chronic obstructive pulmonary disease	0.00016	0.00214	CbGpPWpGaD
Tolbutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.0021	CbGpPWpGaD
Tolbutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.00209	CbGpPWpGaD
Tolbutamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00207	CbGpPWpGaD
Tolbutamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00394	CcSEcCtD
Tolbutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00186	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000137	0.00184	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000136	0.00182	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000135	0.00182	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000135	0.00182	CbGpPWpGaD
Tolbutamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00351	CcSEcCtD
Tolbutamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00349	CcSEcCtD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000134	0.0018	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GC—chronic obstructive pulmonary disease	0.000132	0.00177	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000132	0.00177	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GC—chronic obstructive pulmonary disease	0.000128	0.00172	CbGpPWpGaD
Tolbutamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00331	CcSEcCtD
Tolbutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.0017	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000123	0.00165	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000122	0.00164	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000121	0.00162	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000119	0.0016	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00153	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000113	0.00152	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00151	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000112	0.0015	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.0015	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.00148	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000106	0.00142	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000105	0.00141	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000104	0.0014	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GC—chronic obstructive pulmonary disease	0.000103	0.00138	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00136	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.00134	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.64e-05	0.0013	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.61e-05	0.00129	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.56e-05	0.00128	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.48e-05	0.00127	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.47e-05	0.00127	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.35e-05	0.00126	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.25e-05	0.00124	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.12e-05	0.00123	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.95e-05	0.0012	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.88e-05	0.00119	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.79e-05	0.00118	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GC—chronic obstructive pulmonary disease	8.71e-05	0.00117	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.71e-05	0.00117	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.59e-05	0.00115	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.58e-05	0.00115	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.46e-05	0.00114	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.34e-05	0.00112	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.26e-05	0.00111	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	8.21e-05	0.0011	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.14e-05	0.00109	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.1e-05	0.00109	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.82e-05	0.00105	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.77e-05	0.00104	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.71e-05	0.00104	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.71e-05	0.00104	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.67e-05	0.00103	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.61e-05	0.00102	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.37e-05	0.00099	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.27e-05	0.000977	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.21e-05	0.000969	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	7.13e-05	0.000958	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.09e-05	0.000953	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.99e-05	0.00094	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.99e-05	0.000939	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.94e-05	0.000933	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	6.91e-05	0.000929	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.8e-05	0.000913	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.72e-05	0.000903	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.64e-05	0.000893	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.63e-05	0.000891	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.53e-05	0.000877	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	6.5e-05	0.000874	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.45e-05	0.000867	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.32e-05	0.000849	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	6.31e-05	0.000848	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.99e-05	0.000805	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.93e-05	0.000797	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.81e-05	0.000781	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.69e-05	0.000765	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.62e-05	0.000755	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	5.55e-05	0.000746	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.41e-05	0.000726	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.28e-05	0.00071	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	5.07e-05	0.000681	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5e-05	0.000672	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.93e-05	0.000662	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.85e-05	0.000651	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.78e-05	0.000642	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.76e-05	0.000639	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.74e-05	0.000636	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.7e-05	0.000632	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.67e-05	0.000627	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.59e-05	0.000617	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.45e-05	0.000599	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.4e-05	0.000591	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.39e-05	0.000589	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.36e-05	0.000586	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.35e-05	0.000585	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.29e-05	0.000577	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.28e-05	0.000575	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.23e-05	0.000568	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.22e-05	0.000567	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.17e-05	0.00056	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.98e-05	0.000535	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.95e-05	0.000531	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.93e-05	0.000528	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.92e-05	0.000527	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.89e-05	0.000523	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.89e-05	0.000523	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.85e-05	0.000518	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.84e-05	0.000516	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.82e-05	0.000513	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.58e-05	0.000481	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.58e-05	0.000481	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.55e-05	0.000477	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.55e-05	0.000477	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.48e-05	0.000468	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000456	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.3e-05	0.000443	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.25e-05	0.000437	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.24e-05	0.000435	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.17e-05	0.000426	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.03e-05	0.000407	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	2.96e-05	0.000398	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.87e-05	0.000386	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	2.87e-05	0.000386	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.00038	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.00038	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	2.75e-05	0.000369	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000347	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.34e-05	0.000314	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.31e-05	0.000311	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	2.31e-05	0.00031	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	2.21e-05	0.000296	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.15e-05	0.00029	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.11e-05	0.000283	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.09e-05	0.00028	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.06e-05	0.000277	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.95e-05	0.000262	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.94e-05	0.000261	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000258	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000256	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.88e-05	0.000253	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.000253	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.87e-05	0.000251	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.75e-05	0.000236	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.73e-05	0.000233	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000231	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.62e-05	0.000218	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.6e-05	0.000215	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000213	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.49e-05	0.0002	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.45e-05	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.43e-05	0.000192	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.41e-05	0.00019	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.33e-05	0.000179	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000177	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000175	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000169	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000163	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000154	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.6e-06	0.000129	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.18e-06	0.000123	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.57e-06	0.000115	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.19e-06	0.00011	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.81e-06	0.000105	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.47e-06	0.0001	CbGpPWpGaD
